Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis

AIMS: Wildtype transthyretin amyloid cardiomyopathy is an under‐recognized cause of heart failure in elderly patients. Transcatheter tricuspid valve repair is a newly emerging therapeutic option for severe tricuspid regurgitation (TR). We present first insights into safety and possible benefits of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoerbrand, Isabel A., Volz, Martin J., Aus dem Siepen, Fabian, Aurich, Matthias, Schlegel, Philipp, Geis, Nicolas A., Hegenbart, Ute, Konstandin, Mathias H., Frey, Norbert, Raake, Philip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053172/
https://www.ncbi.nlm.nih.gov/pubmed/36514259
http://dx.doi.org/10.1002/ehf2.14262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053172/
https://www.ncbi.nlm.nih.gov/pubmed/36514259
http://dx.doi.org/10.1002/ehf2.14262

Ejemplares similares